Suppr超能文献

多种钠通道亚型和丝裂原活化蛋白激酶存在于疼痛性人类神经瘤中。

Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas.

作者信息

Black Joel A, Nikolajsen Lone, Kroner Karsten, Jensen Troels S, Waxman Stephen G

机构信息

Department of Neurology and Center for Neuroscience and Regeneration Research, Yale School of Medicine, New Haven, USA.

出版信息

Ann Neurol. 2008 Dec;64(6):644-53. doi: 10.1002/ana.21527.

Abstract

OBJECTIVE

Although axons within neuromas have been shown to produce inappropriate spontaneous ectopic discharges, the molecular basis for pain in patients with neuromas is still not fully understood. Because sodium channels are known to play critical roles in neuronal electrogenesis and hyperexcitability, we examined the expression of all the neuronal voltage-gated sodium channels (Nav1.1, Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9) within human painful neuromas. We also examined the expression of two mitogen-activated protein (MAP) kinases, activated p38 and extracellular signal-regulated kinases 1 and 2 (ERK1/2), which are known to contribute to chronic pain, within these human neuromas.

METHODS

We used immunocytochemical methods with specific antibodies to sodium channels Nav1.1, Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9, and to activated MAP kinases p38 and ERK1/2 to study by confocal microscopy control and painful neuroma tissue from five patients with well-documented pain.

RESULTS

We demonstrate upregulation of sodium channel Nav1.3, as well as Nav1.7 and Nav1.8, in blind-ending axons within human painful neuromas. We also demonstrate upregulation of activated p38 and ERK1/2 MAP kinases in axons within these neuromas.

INTERPRETATION

These results demonstrate that multiple sodium channel isoforms (Nav1.3, Nav1.7, and Nav1.8), as well as activated p38 and ERK1/2 MAP kinases, are expressed in painful human neuromas, indicating that these molecules merit study as possible therapeutic targets for the treatment of pain associated with traumatic neuromas.

摘要

目的

尽管已表明神经瘤内的轴突会产生不适当的自发性异位放电,但神经瘤患者疼痛的分子基础仍未完全明确。由于已知钠通道在神经元电活动和兴奋性过高方面起关键作用,我们检测了人类疼痛性神经瘤内所有神经元电压门控钠通道(Nav1.1、Nav1.2、Nav1.3、Nav1.6、Nav1.7、Nav1.8和Nav1.9)的表达。我们还检测了两种丝裂原活化蛋白(MAP)激酶,即活化的p38以及细胞外信号调节激酶1和2(ERK1/2)在这些人类神经瘤内的表达,已知这些激酶与慢性疼痛有关。

方法

我们使用针对钠通道Nav1.1、Nav1.2、Nav1.3、Nav1.6、Nav1.7、Nav1.8和Nav1.9以及活化的MAP激酶p38和ERK1/2的特异性抗体,通过免疫细胞化学方法,利用共聚焦显微镜研究了来自五名有明确疼痛记录患者的对照和疼痛性神经瘤组织。

结果

我们证实在人类疼痛性神经瘤内的盲端轴突中,钠通道Nav1.3以及Nav1.7和Nav1.8上调。我们还证实在这些神经瘤的轴突中活化的p38和ERK1/2 MAP激酶上调。

解读

这些结果表明多种钠通道亚型(Nav1.3、Nav1.7和Nav1.8)以及活化的p38和ERK1/2 MAP激酶在人类疼痛性神经瘤中表达,这表明这些分子作为治疗与创伤性神经瘤相关疼痛的可能治疗靶点值得研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验